Latest articles in Health
A new study shows AI-assisted mammography systems can detect approximately 20% of breast cancer cases up to six years before conventional diagnosis. The finding could transform screening protocols and improve survival rates. Separately, GLP-1 drugs show promise for bone health in type 2 diabetes patients, and FDA proposes banning bulk compounding of popular weight-loss drugs.
A surprising new study published June 14 in ScienceDaily reports that completely eliminating sugar from the diet may backfire. Mice fed a sucrose-free low-fat diet showed worse blood sugar control, increased inflammation, disrupted gut bacteria, and signs of fatty liver compared to mice that consumed some sugar. The findings challenge the assumption that zero-sugar diets are universally beneficial.
The FDA approved bemotrizinol, the first new sunscreen active ingredient in 25 years, marking a major milestone in sun protection. The approval comes as skin cancer rates continue to rise and public awareness of UV damage grows. In other health news, a study linking vaccines to autism was retracted, the FDA issued a safety alert on weight-loss drug kidney risks, and GLP-1 medications show promise in reducing harmful fat while preserving muscle mass.
The FDA's vaccine advisory committee recommended that the 2026-2027 COVID-19 vaccine formula target the JN.1-lineage XFG variant, the preferred strain for an updated monovalent shot. The decision follows evidence that this variant most closely matches currently circulating SARS-CoV-2 viruses. Updated vaccines from Moderna and Pfizer are expected to roll out in September 2026 alongside the annual flu shot campaign.
AI-powered mammography systems are detecting one in five breast cancer cases up to six years before conventional diagnosis, according to new research. The findings suggest AI screening could dramatically improve survival rates through earlier intervention. Separately, a new oral GLP-1 drug lowered blood sugar levels by 7% in people with type 2 diabetes, and Congo's confirmed Ebola cases rose to 676 with 136 deaths. Researchers also discovered 45 new toxins produced by Salmonella bacteria, opening new avenues for treatment.
The FDA issued a safety alert on Wednesday requiring all orlistat products — including over-the-counter Alli and prescription Xenical — to carry new warnings about kidney stones and acute kidney injury. The label change follows a review of 12 cases of kidney complications linked to the drug, with patients averaging 61 years old and a median exposure of 2.5 months before injury. Eight patients required hospitalization and five needed dialysis. Separately, studies linked GLP-1 drugs to lower cancer risk and found glucosamine tied to faster Alzheimer's progression.
A new study from UC San Diego provides the first randomized, placebo-controlled clinical evidence that semaglutide, the active ingredient in Ozempic and Wegovy, slows down the accumulation of biological aging markers in human DNA. The research, focused on adults with HIV who experience accelerated aging, found that the drug calms inflammation and reduces excess fat to postpone molecular signs of aging. Separately, Ebola spread in central Africa is raising concerns it could match the 2014 record outbreak.
The largest real-world study of the maternal RSV vaccine found it reduces the risk of infant hospitalization by over 80% when given at least two weeks before birth. The UK Health Security Agency study, presented at ESCMID Global 2026, provides robust evidence that vaccination offers substantial protection against severe illness in young infants.
The FDA has proposed removing semaglutide, tirzepatide, and liraglutide from the 503B Bulks List, effectively banning outsourcing facilities from compounding these GLP-1 drugs in bulk. The move targets compounded versions of Ozempic, Wegovy, Mounjaro, and Zepbound that are sold at a fraction of the brand-name price.
Researchers at McMaster University have discovered manikomycin, a new antibiotic that kills drug-resistant bacteria including salmonella, E. coli, and klebsiella by targeting a previously unknown part of the bacterial ribosome. The compound was hidden in a decades-old soil bacterium and was uncovered using advanced laboratory techniques. It is not toxic to human cells and has no observed resistance in tested superbugs.